Heart healing hope: new drug targets scarring in diabetic kidney patients
NCT ID NCT07442448
First seen Mar 03, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study tests whether a daily pill called finerenone can reduce fat and scarring in the heart muscle of people with diabetic kidney disease and heart failure. About 40 adults will take the drug for 6 months and get advanced heart scans to measure changes. The goal is to see if finerenone can slow or reverse heart damage, not cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cathay General Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.